DRUG · Mapped RxNorm record
lamotrigine
Normalized identity: lamotrigineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
NCT00917839
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedThe Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
lamotrigineDRUG · verified · RxNorm: lamotrigine
Sponsors & collaborators
Cantonal Hospital of St. Gallenlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00917839 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.